VICE Special Report: KILLING CANCER Airs 02.27.15



VICE starts a bit earlier than announced this season. The third season technically does not begin until March 06, 2015, but VICE has prepared an hour-long Special Report it wants to address to HBO audiences before then. Here is the official Press release regarding KILLING CANCER, a report about the latest, cutting-edge treatments out there.




HIV, measles and viruses that have killed millions are now

being used against one of the world’s deadliest diseases to save lives


VICE SPECIAL REPORT: KILLING CANCER goes inside the world’s most cutting-edge cancer research labs to follow the pioneering doctors and researchers who are changing the face of modern-day medicine and meet some of the cancer survivors who have already been saved by this revolutionary medical breakthrough. The exclusive in-depth special debuts FRIDAY, FEBRUARY 27 (10:00-11:00 p.m. ET/PT), one week before the Emmy-winning series kicks off its third season 03.06.15.


In one of the most comprehensive reports on the subject to date, VICE explores groundbreaking new treatments to fight leukemia, glioblastoma and multiple myeloma. These therapies include: the use of HIV to transform a patient’s immune system into a cancer-killing machine; a genetically engineered cold virus injected into a living patient’s brain tumor; and millions of doses of measles infused into patients’ bloodstreams.


VICE SPECIAL REPORT: KILLING CANCER is executive produced by Bill Maher, Shane Smith, Eddy Moretti and BJ Levin; co-executive producer, Jonah Kaplan; consulting producer, Fareed Zakaria.

This is not the first time VICE has explored medical issue on the series, but it is a first time Special report for HBO and the first hour long piece we have had. Here is a preview clip:

Hopefully, there can be more VICE Special reports to follow. We will have more details as HBOWatch reviews this report. And, of course, we will be right there every step of the way through VICE Season Three. Don’t miss it. Peace.

Add a Comment

Your email address will not be published. Required fields are marked *